- Home
- VANI
as 01-17-2025 4:00pm EST
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | ALAMEDA |
| Market Cap: | 69.9M | IPO Year: | 2014 |
| Target Price: | $3.00 | AVG Volume (30 days): | 134.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.01 - $7.80 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Vivani Medical Inc. (DE) (VANI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Williams Gregg | VANI | Director10% Owner | Nov 8 '24 | Buy | $1.26 | 3,968,253 | $4,999,998.78 | 4,695,861 |
Latest Vivani Medical Inc. (DE) News
VANI Breaking Stock News: Dive into VANI Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now
Medical Device Network
a month ago
Vivani begins exenatide implant trial for obesity in Australia
Business Wire
a month ago
Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
Benzinga
a month ago
EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia
Business Wire
a month ago
Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast
Simply Wall St.
2 months ago
Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares
Associated Press Finance
2 months ago
Vivani Medical: Q3 Earnings Snapshot
Business Wire
2 months ago
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
Compare VANI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VANI Vivani Medical Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.